Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy-Reference-Cited by-同舟云学术

Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy

Published:2014-10 Issue:10 Volume:10 Page:4257-4268
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Chen Zhuo^ORCID,Xu Peng,Chen Jincan,Chen Hongwei,Hu Ping,Chen Xueyuan,Lin Lin,Huang Yunmei,Zheng Ke,Zhou Shanyong,Li Rui,Chen Song,Liu Jianyong,Xue Jinping,Huang Mingdong

Funder

National Natural Science Foundation

National Major Scientific Equipment Development of China

Scientific Equipment Development Project of the CAS

Strategic Priority Research Program of the CAS

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference60 articles.

1. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT;Robertson;J Photochem Photobiol B,2009

2. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity;Garg;Apoptosis,2010

3. Strategies for selective delivery of photodynamic sensitisers to biological targets;Hudson;J Porphyrins Phthalocyanines,2004

4. Synthesis and properties of photo-activable phthalocyanines: a brief overview;Wang;J Inclusion Phenom Macrocyclic Chem,2011

5. Photodynamic therapy in oncology;Triesscheijn;Oncologist,2006

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Characterization of a New Zwitterionic Phthalocyanine for Efficient Synthesis of Polyhydroquinoline and Chromene Derivatives;ChemistrySelect;2024-07-12

2. Albumin-based drug carrier targeting urokinase receptor for cancer therapy;International Journal of Pharmaceutics;2023-03

3. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer;Journal of Translational Medicine;2022-03-18

4. Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer;Cancers;2022-01-19

5. Development of inhibitors for uPAR: blocking the interaction of uPAR with its partners;Drug Discovery Today;2021-04